Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Open Trial to Evaluate Efficacy of Fentanyl Pectin Nasal Spray vs Physician Choice-Usual Care in Reducing Predictable Breakthrough Pain at Swallowing in Head/Neck Cancer Patients Undergoing Radiotherapy

NCT01980498 is registered in ClinicalTrials.gov with L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A. as lead sponsor.

NCT NCT01980498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01980498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Open Trial to Evaluate Efficacy of Fentanyl Pectin Nasal Spray vs Physician Choice-Usual Care in Reducing Predictable Breakthrough Pain at Swallowing in Head/Neck Cancer Patients Undergoing Radiotherapy
Lead sponsor
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Phase
Phase 3
Overall status
Withdrawn
Start date
September 30, 2014
Completion date
September 30, 2015
Enrollment
0 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

predictable btp at swallowing in in head/neck cancer patients undergoing radiotherapy already receiving opioid therapy for background pain